-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
RAPT Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2023.
- RAPT Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 38.9M shares, a 1.42% increase year-over-year.
- RAPT Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 38.3M shares, a 17.8% increase from 2022.
- RAPT Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 32.5M shares, a 18.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)